Enabling Healthcare 4.0 for Pandemics

12 Chapter 13Figure 13.1 Impact of COVID-19 on IoT market. e: estimated; p: projected.Figure 13.2 Processes utilized by IoT for COVID-19.Figure 13.3 IoT innovations and its enthusiasm among the organizations.Figure 13.4 Healthcare framework based on IoT.Figure 13.5 Components of Smart disease surveillance.Figure 13.6 Conceptual view of Smart disease surveillance system.Figure 13.7 The conceptual diagram shown above demonstrates the integrated IoT s...Figure 13.8 Key merits of IoT.Figure 13.9 Issues in implementing IoT.

13 Chapter 14Figure 14.1 Mechanism of infection resulting from SARS-COV 2 infection [6].Figure 14.2 Source: India’s Ministry of Health and family welfare [37].Figure 14.3 Logistic growth of COVID-19 infection for Germany [40].Figure 14.4 Logistic growth of COVID-19 infection for Italy [40].Figure 14.5 Growth of Corona patients in India [41].Figure 14.6 SIR model for Japan [16].Figure 14.7 SIR model for Italy [16].Figure 14.8 Distribution of probability of last scale of the outbreak [48].

14 Chapter 15Figure 15.1 Test statistics of India till 6th May 2020 [3].Figure 15.2 Lock down analysis phase-1 [4].Figure 15.3 Regression analysis lockdown phase-1 [4].Figure 15.4 Lock down analysis phase-2 [14].Figure 15.5 Regression analysis of lockdown phase-2 [14].Figure 15.6 Lock down analysis phase-3 [15].Figure 15.7 15-day analysis of COVID-19 cases in Maharashtra [14].Figure 15.8 15-day analysis of COVID-19 cases in Delhi [15].Figure 15.9 Actual vs predicted confirmed cases for Delhi.Figure 15.10 Actual vs predicted confirmed cases for Maharashtra.

1 Chapter 7Table 7.1 Technological strategies adopted by various countries during the outbr...Table 7.2 Technologies and their use during the outbreak of SARS.Table 7.3 Technological strategies adapted by various countries during the outbr...Table 7.4 Technologies and their use during the outbreak of Ebola.Table 7.5 Future technologies that can be deployed to limit the spread of simila...

2 Chapter 8Table 8.1 A quantitative measure of pandemics based on crucial factors.Table 8.2 Digital technology for COVID-19 management.

3 Chapter 9Table 9.1 Classification of bio-sensors.Table 9.2 Comparison of various technologies.

4 Chapter 10Table 10.1 Total reported cases and death cases due to Corona Virus are shown be...

5 Chapter 11Table 11.1 Benchmark results of APGWO vs GWO and PSO.Table 11.2 Example of the initial solution.Table 11.3 Summarized results (rounded up).Table 11.4 Summarized gap.

6 Chapter 14Table 14.1 Significant countries affected by the CODIV-19 pandemic [16].

7 Chapter 15Table 15.1 COVID-2019 data of five different countries on May 7, 2020 [1].Table 15.2 Different machine learning algorithm adopted by different researchers...Table 15.3 COVID-19 data of five highly infected States of India [4].Table 15.4 Value of performance evaluator parameter for training and testing dat...Table 15.5 Value of performance evaluator parameter for training and testing dat...

1 v

2 ii

3 iii

4 iv

5 xv

6 xvi

7 xvii

8 xviii

9 1

10 3

11 4

12 5

13 6

14 7

15 8

16 9

17 10

18 11

19 12

20 13

21 14

22 15

23 16

24 17

25 18

26 19

27 21

28 22

29 23

30 24

31 25

32 26

33 27

34 28

35 29

36 30

37 31

38 32

39 33

40 34

41 35

42 36

43 37

44 38

45 39

46 40

47 41

48 42

49 43

50 44

51 45

52 46

53 47

54 48

55 49

56 50

57 51

58 52

59 53

60 54

61 55

62 56

63 57

64 59

65 60

66 61

67 62

68 63

69 64

70 65

71 66

72 67

73 68

74 69

75 70

76 71

77 72

78 73

79 75

80 76

81 77

82 78

83 79

84 80

85 81

86 82

87 83

88 84

89 85

90 86

91 87

92 88

93 89

94 90

95 91

96 93

97 94

98 95

99 96

100 97

101 98

102 99

103 100

104 101

105 102

106 103

107 104

108 105

109 106

110 107

111 108

112 109

113 110

114 111

115 112

116 113

117 114

118 115

119 117

120 118

121 119

122 120

123 121

124 122

125 123

126 124

127 125

128 126

129 127

130 128

131 129

132 130

133 131

134 132

135 133

136 134

137 135

138 136

139 137

140 138

141 139

142 140

143 141

144 143

145 144

146 145

147 146

148 147

149 148

150 149

151 150

152 151

153 152

154 153

155 154

156 155

157 156

158 157

159 158

160 159

161 160

162 161

163 163

164 164

165 165

166 166

167 167

168 168

169 169

170 170

171 171

172 172

173 173

174 174

175 175

176 176

177 177

178 178

179 179

180 180

181 181

182 182

183 183

184 184

185 185

186 186

187 187

188 188

189 189

190 190

191 191

192 192

193 193

194 194

195 195

196 196

197 197

198 198

199 199

200 200

201 201

202 202

203 203

204 204

205 205

206 206

207 207

208 208

209 209

210 211

211 213

212 214

213 215

214 216

215 217

216 218

217 219

218 220

219 221

220 222

221 223

222 224

223 225

224 226

225 227

226 228

227 229

228 230

229 231

230 232

231 233

232 234

233 235

234 237

235 238

236 239

237 240

238 241

239 242

240 243

241 244

242 245

243 246

244 247

245 248

246 249

247 250

248 251

249 252

250 253

251 254

252 255

253 256

254 257

255 258

256 259

257 260

258 261

259 262

260 263

261 264

262 265

263 266

264 267

265 268

266 269

267 270

268 271

269 272

270 273

271 274

272 275

273 276

274 277

275 278

276 279

277 280

278 281

279 282

280 283

281 284

282 285

283 286

284 287

285 288

286 289

287 290

288 291

289 292

290 293

291 294

292 295

293 296

294 297

295 299

296 300

297 301

298 302

299 303

300 304

301 305

302 306

303 307

304 308

305 309

306 310

307 311

308 312

309 313

310 314

311 315

312 316

313 317

314 318

315 319

316 320

317 321

Scrivener Publishing100 Cummings Center, Suite 541J Beverly, MA 01915-6106

Publishers at Scrivener Martin Scrivener ( martin@scrivenerpublishing.com) Phillip Carmical ( pcarmical@scrivenerpublishing.com)

Edited by

Abhinav Juneja

Vikram Bali

Sapna Juneja

Vishal Jain

Prashant Tyagi

This edition first published 2021 by John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, USA and Scrivener Publishing LLC, 100 Cummings Center, Suite 541J, Beverly, MA 01915, USA